CNY 7.83
(0.38%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | 220.46 Million CNY | -6.72% |
2022 | 198.4 Million CNY | 9.98% |
2021 | 203.77 Million CNY | 22.03% |
2020 | 177.55 Million CNY | 6.71% |
2019 | 315.72 Million CNY | 1.76% |
2018 | 143.73 Million CNY | 18.56% |
2017 | 112.37 Million CNY | 11.82% |
2016 | 110.63 Million CNY | 16.62% |
2015 | 81.15 Million CNY | 9.77% |
2014 | 82.62 Million CNY | -26.88% |
2013 | 91.78 Million CNY | 9.82% |
2012 | 102.96 Million CNY | 29.21% |
2011 | 80.85 Million CNY | 19.17% |
2010 | 64.25 Million CNY | 7.44% |
2009 | 60.87 Million CNY | 6.15% |
2008 | 58.72 Million CNY | 14.18% |
2007 | 52.17 Million CNY | 23.71% |
2006 | 43.52 Million CNY | -7.03% |
2005 | 46.81 Million CNY | 13.79% |
2004 | 41.73 Million CNY | -20.01% |
2003 | 48.85 Million CNY | 29.76% |
2002 | 39.63 Million CNY | -17.86% |
2001 | 48.25 Million CNY | -22.47% |
2000 | 61.46 Million CNY | 36.64% |
1999 | 43.71 Million CNY | 8.99% |
1998 | 41.79 Million CNY | 63.7% |
1997 | 25.53 Million CNY | 292.66% |
1996 | 6.5 Million CNY | 2.04% |
1995 | 6.37 Million CNY | 16.12% |
1994 | 5.48 Million CNY | -40.77% |
1993 | 9.26 Million CNY | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q2 | 51.3 Million CNY | 61.89% |
2024 Q3 | 3.82 Million CNY | -92.66% |
2024 Q1 | 26.96 Million CNY | -13.04% |
2023 Q1 | 26.84 Million CNY | -42.88% |
2023 Q3 | 26.18 Million CNY | -36.95% |
2023 Q2 | 41.52 Million CNY | 54.67% |
2023 Q4 | 37.93 Million CNY | 44.87% |
2023 FY | - CNY | -6.72% |
2022 Q2 | 33.98 Million CNY | 72.67% |
2022 Q3 | 18.34 Million CNY | -46.04% |
2022 FY | - CNY | 9.98% |
2022 Q4 | 47 Million CNY | 156.3% |
2022 Q1 | 19.68 Million CNY | -28.31% |
2021 Q2 | 38.13 Million CNY | 86.39% |
2021 Q4 | 27.45 Million CNY | 64.03% |
2021 Q3 | 16.73 Million CNY | -56.11% |
2021 FY | - CNY | 22.03% |
2021 Q1 | 20.46 Million CNY | -15.4% |
2020 Q3 | 29.21 Million CNY | -37.6% |
2020 FY | - CNY | 6.71% |
2020 Q1 | 16.61 Million CNY | -28.85% |
2020 Q2 | 46.82 Million CNY | 181.9% |
2020 Q4 | 24.18 Million CNY | -17.22% |
2019 Q2 | 36.84 Million CNY | 95.27% |
2019 Q1 | 18.86 Million CNY | 15.52% |
2019 FY | - CNY | 1.76% |
2019 Q3 | 23.5 Million CNY | -36.19% |
2019 Q4 | 23.34 Million CNY | -0.69% |
2018 Q2 | 36.56 Million CNY | 126.33% |
2018 Q1 | 16.15 Million CNY | 43.89% |
2018 Q4 | 16.33 Million CNY | -8.08% |
2018 FY | - CNY | 18.56% |
2018 Q3 | 17.76 Million CNY | -51.41% |
2017 Q4 | 11.22 Million CNY | 135.46% |
2017 Q2 | 44.86 Million CNY | 294.87% |
2017 FY | - CNY | 11.82% |
2017 Q3 | 4.76 Million CNY | -89.37% |
2017 Q1 | 11.36 Million CNY | -48.81% |
2016 Q3 | 3.1 Million CNY | -86.69% |
2016 Q1 | 11.42 Million CNY | -63.51% |
2016 Q2 | 23.31 Million CNY | 104.02% |
2016 Q4 | 22.19 Million CNY | 615.1% |
2016 FY | - CNY | 16.62% |
2015 FY | - CNY | 9.77% |
2015 Q4 | 31.32 Million CNY | 2839.99% |
2015 Q3 | 1.06 Million CNY | -73.84% |
2015 Q2 | 4.07 Million CNY | -48.69% |
2015 Q1 | 7.93 Million CNY | 54.37% |
2014 FY | - CNY | -26.88% |
2014 Q4 | 5.14 Million CNY | -46.62% |
2014 Q3 | 9.63 Million CNY | -61.53% |
2014 Q2 | 25.03 Million CNY | 30.65% |
2014 Q1 | 19.16 Million CNY | -30.47% |
2013 FY | - CNY | 9.82% |
2013 Q3 | 16.58 Million CNY | -14.04% |
2013 Q4 | 27.56 Million CNY | 66.15% |
2013 Q1 | 18.64 Million CNY | 8.22% |
2013 Q2 | 19.29 Million CNY | 3.5% |
2012 Q2 | 17.96 Million CNY | 1.9% |
2012 Q3 | 19.28 Million CNY | 7.37% |
2012 Q4 | 17.23 Million CNY | -10.66% |
2012 FY | - CNY | 29.21% |
2012 Q1 | 17.62 Million CNY | 97.0% |
2011 Q1 | 12.37 Million CNY | 4.86% |
2011 Q4 | 8.94 Million CNY | -27.2% |
2011 FY | - CNY | 19.17% |
2011 Q2 | 10.35 Million CNY | -16.29% |
2011 Q3 | 12.29 Million CNY | 18.64% |
2010 Q4 | 11.8 Million CNY | 29.49% |
2010 Q1 | 9.09 Million CNY | -2.67% |
2010 Q2 | 7.21 Million CNY | -20.68% |
2010 Q3 | 9.11 Million CNY | 26.36% |
2010 FY | - CNY | 7.44% |
2009 FY | - CNY | 6.15% |
2009 Q1 | 8.34 Million CNY | 40.11% |
2009 Q2 | 6.88 Million CNY | -17.57% |
2009 Q3 | 7.66 Million CNY | 11.46% |
2009 Q4 | 9.34 Million CNY | 21.82% |
2008 Q3 | 6.45 Million CNY | -49.15% |
2008 Q1 | 7.62 Million CNY | -10.33% |
2008 FY | - CNY | 14.18% |
2008 Q4 | 5.95 Million CNY | -7.76% |
2008 Q2 | 12.7 Million CNY | 66.54% |
2007 FY | - CNY | 23.71% |
2007 Q4 | 8.5 Million CNY | 24.36% |
2007 Q3 | 6.83 Million CNY | 88.35% |
2007 Q2 | 3.63 Million CNY | -13.88% |
2007 Q1 | 4.21 Million CNY | -57.42% |
2006 Q3 | 9.66 Million CNY | -33.25% |
2006 Q4 | 9.9 Million CNY | 2.48% |
2006 FY | - CNY | -7.03% |
2006 Q2 | 14.47 Million CNY | 19.79% |
2006 Q1 | 12.08 Million CNY | 132.82% |
2005 FY | - CNY | 13.79% |
2005 Q1 | -16.63 Million CNY | -201.93% |
2005 Q2 | 40.24 Million CNY | 341.87% |
2005 Q3 | 4.04 Million CNY | -89.94% |
2005 Q4 | 5.19 Million CNY | 28.23% |
2004 Q2 | 11.63 Million CNY | 18.51% |
2004 Q4 | 16.32 Million CNY | 179.16% |
2004 FY | - CNY | -20.01% |
2004 Q3 | 5.84 Million CNY | -49.73% |
2004 Q1 | 9.81 Million CNY | -52.45% |
2003 Q3 | 9.22 Million CNY | -40.66% |
2003 FY | - CNY | 29.76% |
2003 Q4 | 20.64 Million CNY | 123.83% |
2003 Q1 | 6.82 Million CNY | 37.42% |
2003 Q2 | 15.54 Million CNY | 127.73% |
2002 Q3 | 4.64 Million CNY | -87.87% |
2002 Q4 | 4.96 Million CNY | 6.98% |
2002 Q2 | 38.28 Million CNY | 263.54% |
2002 Q1 | -23.4 Million CNY | 0.0% |
2002 FY | - CNY | -17.86% |
2001 FY | - CNY | -22.47% |
2000 FY | - CNY | 36.64% |
1999 FY | - CNY | 8.99% |
1998 FY | - CNY | 63.7% |
1997 FY | - CNY | 292.66% |
1996 FY | - CNY | 2.04% |
1995 FY | - CNY | 16.12% |
1994 FY | - CNY | -40.77% |
1993 FY | - CNY | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
Zhejiang Int'l Group Co.,Ltd. | 1.14 Billion CNY | 80.689% |
Hunan Jingfeng Pharmaceutical Co.,Ltd. | -83.34 Million CNY | 364.525% |
Hubei Guangji Pharmaceutical Co., Ltd. | -2.67 Million CNY | 8351.659% |
Yifan Pharmaceutical Co., Ltd. | -483.52 Million CNY | 145.595% |
Guangdong Jiaying Pharmaceutical Co., Ltd | 66.15 Million CNY | -233.272% |
Sichuan Kelun Pharmaceutical Co., Ltd. | 4.85 Billion CNY | 95.462% |
Chongqing Lummy Pharmaceutical Co., Ltd. | 116.49 Million CNY | -89.247% |
Boai NKY Medical Holdings Ltd. | 665.28 Million CNY | 66.862% |
Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. | 391.09 Million CNY | 43.629% |